Alpha Cognition Inc.
VANCOUVER, A1 · Founded 2014 · CIK 0001655923 · Biotech · Public
Therapeutic treatments for Alzheimer's and ALS
alphacognition.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $28M
- 17 Form D · Nov 2024
- 23 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 12
- 5 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $650,000 | |
| Private capital raised | Form D · SEC | $385,000 | |
| Private capital raised | Form D · SEC | $200,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $5,951,093 | |
| Private capital raised | Form D · SEC | $1,915,000 | |
| Private capital raised | Form D · SEC | $1,457,000 | |
| Private capital raised | Form D · SEC | $424,983 | |
| Private capital raised | Form D · SEC | $1,847,827 | |
| Private capital raised | Form D · SEC | $1,286,748 | |
| Private capital raised | Form D · SEC | $1,260,837 | |
| Private capital raised | Form D · SEC | $343,999 | |
| Private capital raised | Form D · SEC | $1,009,999 | |
| Private capital raised | Form D · SEC | $1,762,097 | |
| Private capital raised | Form D · SEC | $2,839,628 | |
| Private capital raised | Form D · SEC | $4,545,000 | |
| Private capital raised | Form D · SEC | $346,944 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1735 | STRYKAGEN CORPORATION | — | — |
| 1736 | MB RESEARCH LABORATORIES, INC. | — | — |
| 1737 | EpimedX, LLC | — | — |
| 1738 | Alpha Cognition Inc. | — | $28M |
| 1739 | Opprtna Therapeutics, Inc. | — | $125K |
| 1740 | IMMUNOPHOTONICS INC | — | $18M |
| 1741 | Superluminal Medicines | — | $116M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Rajeev BakshiDirector
- Rob BakshiDirector
- Kenneth CawkellDirector · Executive Officer
- Lauren D'AngeloExecutive Officer
- Henry DuExecutive Officer
- Anthony GiovinazzoDirector
- John HavensDirector
- Don KalkofenExecutive Officer
- Denis KayExecutive Officer
- Alfred MaelickeDirector
- Michael McFaddenDirector · Executive Officer
- Jeremy MertzDirector
- Len MertzDirector
- Phillip MertzDirector
- Erich MohrDirector
- Frederick SancilioDirector · Executive Officer
- Jeremy WrightExecutive Officer
- Jay YooExecutive Officer
Patents
- ALPHA-1062 For Treating Traumatic Brain Injuryapplication
- ALPHA-1062 For Treating Traumatic Brain Injurygranted
- Dosage Regimens For Benzgalantaminegranted
- Amorphous Solid Forms Of ALPHA-1062 Gluconateapplication
- Coated Tablets For Ph-dependent Release Of Benzgalantamineapplication
- Solid Forms Of ALPHA-1062 Gluconateapplication
- Granulin/epithelin Modules And Combinations Thereof To Treat Neurodegenerative Diseaseapplication
- Coated Tablets For Ph-dependent Release Of Benzgalantaminegranted
- Solid Forms Of ALPHA-1062 Gluconategranted
- Self-preserving Compositions And Multi-use Dispensers For Administering ALPHA-1062application
- Solid Forms Of ALPHA-1062 Gluconategranted
- Benzgalantamine For Treating Persistent Post-concussion Symptomsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.